Congenital Heart Disease Mutation Linked to Kidney Damage
Discovering the link between congenital heart disease and kidney problems could improve outcomes for patients with the disease
Integrating molecular biology, genetic engineering, synthetic biology and systems-level modeling to interrogate and reprogram cellular systems for targeted therapeutic intervention
Drawing from molecular and cell biology, biophysics, evolutionary biology, genetic engineering, and synthetic biology, researchers are developing new ways to read, manipulate, and apply genetic information to better understand disease and create new therapies.
Biomolecular and cellular engineering research in Duke BME focuses on understanding and engineering biological systems at the molecular and cellular levels to advance human health. This work includes gene and drug delivery, tissue engineering, regenerative medicine, synthetic gene circuits, and systems biology approaches that reveal how cells and biological networks function.
By integrating experimental, computational, and clinical methods, Duke BME researchers are developing innovative treatments for genetic disorders, cancer, infectious diseases, and other complex health challenges.
Cellular and molecular engineers in Duke BME form close collaborations with clinicians at the Duke University School of Medicine, faculty in the departments of Chemistry, Biology and Cell Biology, and other key stakeholders.
Discovering the link between congenital heart disease and kidney problems could improve outcomes for patients with the disease
Chory will use robotic platforms to synthesize molecules capable of reaching key proteins affiliated with “undruggable” pediatric cancers
Gerecht was recognized for her trailblazing stem cell and vascular bioengineering research and her steadfast mentorship to young scientists
Gladfelter, a Duke Health Distinguished Professor of Cell Biology and Biomedical Engineering, is a quantitative cell biologist interested in fundamental mechanisms of cell organization
Inhibiting a critical enzyme involved in iron regulation makes cancer cells vulnerable to cell death
The honor from the American Institute for Medical and Biological Engineering represents the top 2% of engineers in the field
Alan L. Kaganov Distinguished Professor of Biomedical Engineering
Associate Dean for Doctoral Education, Theodore Kennedy Professor of BME
Professor in the Thomas Lord Department of Mechanical Engineering and Materials Science
Chair of Biomedical Engineering, Paul M. Gross Distinguished Professor
John W. Strohbehn Distinguished Professor of Biomedical Engineering
Associate Professor in the Department of Biomedical Engineering
Nello L. Teer, Jr. Distinguished Professor Emeritus of Biomedical Engineering, in the Edmund T. Pratt, Jr. School of Engineering
Associate Director of Undergraduate Studies, Assistant Professor of the Practice in the Department of BME
Assistant Professor of the Practice in the Department of Biomedical Engineering
Director of Master’s Studies, W. H. Gardner, Jr. Associate Professor of Biomedical Engineering
Professor of the Practice Emeritus in the Department of Biomedical Engineering
Alfred M. Hunt Faculty Scholar Assistant Professor in the Department of Biomedical Engineering
Coulter Program Director, Professor of Biomedical Engineering
Professor Emeritus of Biomedical Engineering
Director of Graduate Studies, Theo Pilkington Distinguished Professor of BME
Robert Plonsey Distinguished Professor of Biomedical Engineering
Joseph A.C. Wadsworth Distinguished Professor of Ophthalmology
Associate Chair for Education, R. Eugene and Susie E. Goodson Distinguished Professor of Biomedical Engineering
Adjunct Professor in the Department of Orthopaedic Surgery
R. Eugene and Susie E. Goodson Distinguished Professor of Biomedical Engineering
James L. Meriam Distinguished Professor of Biomedical Engineering
Explore additional specialty research areas in Duke BME and throughout the Pratt School of Engineering.